14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.71 Thursday, 25th Apr 2024 CANF stock ended at $1.92. This is 1.03% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.62% from a day low at $1.92 to a day high of $1.97.
90 days $1.91 $2.71
52 weeks $1.71 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Feb 13, 2024 $2.02 $2.04 $2.02 $2.03 10 900
Feb 12, 2024 $2.10 $2.12 $2.05 $2.06 21 365
Feb 09, 2024 $2.05 $2.08 $2.00 $2.06 25 785
Feb 08, 2024 $2.07 $2.08 $2.00 $2.00 8 185
Feb 07, 2024 $2.08 $2.10 $2.03 $2.03 22 934
Feb 06, 2024 $2.05 $2.05 $2.03 $2.03 1 250
Feb 05, 2024 $2.13 $2.13 $2.01 $2.02 10 423
Feb 02, 2024 $2.07 $2.14 $2.01 $2.09 22 961
Feb 01, 2024 $2.06 $2.09 $2.00 $2.06 22 806
Jan 31, 2024 $2.09 $2.15 $2.02 $2.11 17 689
Jan 30, 2024 $2.21 $2.27 $1.95 $2.11 104 314
Jan 29, 2024 $2.04 $2.17 $1.98 $2.10 83 927
Jan 26, 2024 $2.00 $2.00 $1.94 $1.96 12 521
Jan 25, 2024 $1.98 $2.02 $1.93 $1.95 28 821
Jan 24, 2024 $2.01 $2.08 $1.92 $1.99 21 481
Jan 23, 2024 $2.01 $2.01 $1.92 $2.00 13 678
Jan 22, 2024 $1.93 $1.98 $1.92 $1.96 10 248
Jan 19, 2024 $1.96 $1.99 $1.87 $1.93 12 703
Jan 18, 2024 $1.96 $2.02 $1.94 $2.00 11 468
Jan 17, 2024 $2.00 $2.03 $1.98 $2.00 10 037
Jan 16, 2024 $2.01 $2.02 $1.97 $1.99 20 330
Jan 12, 2024 $1.98 $2.09 $1.98 $2.00 19 812
Jan 11, 2024 $2.04 $2.10 $2.02 $2.02 15 952
Jan 10, 2024 $2.03 $2.11 $1.99 $2.05 9 873
Jan 09, 2024 $2.13 $2.13 $2.02 $2.02 4 976
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT